Gliclazide and metformin''"'"'''

Gliclazide and metformin
GLICLAGLAZE M are both medications used in the management of type 2 diabetes. They belong to different classes of antidiabetic drugs and work in distinct ways to help control blood sugar levels.
Gliclazide is a sulfonylurea, which is a class of oral hypoglycemic agents.
 It stimulates the release of insulin from the pancreas, helping to lower blood glucose levels. Sulfonylureas work by increasing the sensitivity of beta cells in the pancreas to glucose.
Gliclazide is used to treat type 2 diabetes when diet and exercise alone do not provide adequate glycemic control. It is typically taken orally in the form of tablets.
Metformin is a biguanide, a different class of oral antidiabetic drugs.
Metformin primarily works by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues. It does not stimulate insulin release from the pancreas.
Metformin is commonly used as a first-line treatment for type 2 diabetes. It is often prescribed alongside lifestyle modifications, such as diet and exercise. Metformin is available in tablet form and may also be used in combination with other antidiabetic medications.
In some cases, healthcare providers may prescribe a combination of GLICLAGLAZE M to enhance glycemic control. This combination allows for the complementary actions of the two medications, addressing different aspects of glucose regulation.
For further information please contact: 
info@sterispharma.com 
Order Now - https://www.sterisonline.com/product/gliclaglaze-m-40-133419